Multiple Sclerosis: Dynamic Market Forecast to 2026
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Multiple Sclerosis (MS) is a rapidly evolving field in which new developments are constantly influencing the market landscape.
The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the MS space, including regulatory, commercial, and clinical events as well as understand how all of these events will impact the projected market forecast.
Scope
The Dynamic Market Forecast consists of a slide deck detailing key market-impacting events that have occurred since the last publication of the MS report, along with an updated Excel-based forecasting model which reflects the projected influence of these events on the future MS market.
The Key Events covered in this MS Dynamic Market Forecast include:
• Patent expiration of Gilenya in 2019 and Aubagio in 2023 will affect sales in the 7MM
• Market launch of the second generation S1P receptor modulators, with same MOA as Gilenya will increase competition.
• Two additional anti-CD20 mAbs, similar to marketed Roche’s Ocrevus are expected to launch
• Positive Phase IIb Trial Results of evobrutinib and its novel MOA could offer a new treatment option for MS patients.
Components of the slide deck include:
• Timeline of market-impacting events
• Key clinical trial landscape updates
• Detailed analysis of the most impactful events, including new primary research to gain Key Opinion Leader perspective
• Overview of updates to the forecast model based on anticipated future impact of events
• Forward-looking events calendar listing expected key updates to the MS competitive space through October 2018-October 2019
Other events included in the analysis include:
• Regulatory filings
• Approval decisions
• Pricing changes
• Patent litigation
• Clinical trial data announcements
• Clinical trial failures
• Clinical trial timeline updates
Reasons to Buy
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global MS market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global MS market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
AB Science
Celgene
Actelion
Biogen
MedDay
Alkermes
GeNeuro
TG Therapeutics
MedicNova
Merck Serono
Merck KGaA
Sanofi
F. Hoffmann-La Roche
Mitsubishi Tanabe Pharma’s
Teva
Servier
Santhera
AbbVie
Serono
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.